TITLE

FDA launches initiative to reduce pump risks

PUB. DATE
June 2010
SOURCE
Hospice Management Advisor;Jun2010, Vol. 15 Issue 6, p67
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on the initiative announced by the U.S. Food and Drug Administration (FDA) to address safety problems related with external infusion pumps. It says that the draft guidance and the letter to manufacturers are the premarket requirements established by the FDA for infusion pumps. It adds that the FDA will also launch a new Web page, which gives information regarding infusion pumps and report safety problems even before new pumps are brought to the market.
ACCESSION #
51378344

 

Related Articles

  • Safety in Question. Fenske, Sean // Medical Design Technology;May2012, Vol. 16 Issue 4, p6 

    The article offers the author's insights on testing and coverage issues related to medical device safety, mentioning that there are people recommending changes to the device review process of the U.S. Food and Drug Administration (FDA).

  • Hundreds of medical devices vulnerable to cyber attacks. PEDERSEN, AMANDA // Medical Device Daily;6/18/2013, Vol. 17 Issue 117, p1 

    The article reports on the vulnerability of hundreds of medical devices to cyber attacks, according to the U.S. Food and Drug Administration (FDA). The agency stated that malicious software or malware has infected many medical devices due to computer viruses in hospital computer networks....

  • A Sentinel For The Industry. Auerbach, Michael // Pharmaceutical Processing;Jun2008, Vol. 23 Issue 6, p6 

    The author reflects on the implementation of Sentinel Initiative by the Food and Drug Administration (FDA) in the U.S. He relates that FDA announced that it is a national, integrated, electronic system for monitoring medical product safety. He claims that he was impressed on the system, after...

  • IAHCSMM VIEWPOINT. New report targets device quality, safety issues. Williamson, Julie E. // Healthcare Purchasing News;Dec2011, Vol. 35 Issue 12, p34 

    In this article the author discusses a report on quality and safety issues related to medical devices that was released in 2011 by the U.S. Food and Drug Administration. She is supportive of several ideas which are discussed in the report and of the positive role that the reports will play in...

  • Safety without borders. Sandnroff, Ronnie // Consumer Reports on Health;Sep2008, Vol. 20 Issue 9, p2 

    The author reflects on the findings of the U.S. Food and Drug Administration (FDA) that drugs and medical devices being manufactured in China are contaminated with another ingredient. She asserts that the FDA will open an office in China and India to work more closely with local authorities and...

  • Transparency and Ethics. Kirst, Julie // 24x7;Oct2009, Vol. 14 Issue 10, p8 

    The article reports on the efforts announced by the U.S. Food and Drug Administration (FDA) to better ensure the safety and effectiveness of medical products. It states that the FDA has the authority to disqualify researchers who conduct clinical trials of new devices if they have not followed...

  • FDA warning to Stryker offers no insight into Neptune recall. McCARTY, MARK // Medical Device Daily;3/26/2013, Vol. 17 Issue 58, p1 

    The article focuses on the warning letter issued to Michigan-based Stryker Instruments by U.S. Food & Drug Administration posted March 6, 2013 and out on March 19, 2013. It states that issued letter detailed for-cause inspection of the firm's plant in Portage, Michigan, and also mentions that...

  • FDA launches initiative to reduce infusion pump risks.  // Healthcare Purchasing News;Jun2010, Vol. 34 Issue 6, p8 

    The article discusses the launch of an initiative by the U.S. Food and Drug Administration (FDA) to reduce the safety issues associated with medication infusion pumps.

  • Medtronic warning calls for outside certification.  // Medical Device Daily;8/22/2012, Vol. 16 Issue 163, p6 

    The article reports on the U.S. Food & Drug Administration (FDA) warning suggesting that Minneapolis, Minnesota-based Medtronic meet with the agency to address the findings associated with the infusion pumps inspection.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics